The Effect of MGCD0103 on CYP450 Isoforms Activity of Rats by Cocktail Method
MGCD0103, an isotype-selective histone deacetylase inhibitor (HDACi), has been clinically evaluated for the treatment of hematologic malignancies and advanced solid tumors, alone and in combination with standard-of-care agents. In order to investigate the effects of MGCD0103 on the metabolic capacit...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2015-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2015/517295 |
id |
doaj-c46ef294b25c492daf5a84d7b77b9b87 |
---|---|
record_format |
Article |
spelling |
doaj-c46ef294b25c492daf5a84d7b77b9b872020-11-24T23:05:19ZengHindawi LimitedBioMed Research International2314-61332314-61412015-01-01201510.1155/2015/517295517295The Effect of MGCD0103 on CYP450 Isoforms Activity of Rats by Cocktail MethodJinzhang Cai0Qingwei Zhang1Kezhi Lin2Lufeng Hu3Yuancai Zheng4The Second Affiliated Hospital & Yuying Children’s Hospital, Wenzhou Medical University, Wenzhou 325000, ChinaShanghai Institute of Pharmaceutical Industry, Shanghai 200437, ChinaMedical Experimental Teaching Center, Wenzhou Medical University, Wenzhou 325035, ChinaThe First Affiliated Hospital, Wenzhou Medical University, Wenzhou 325035, ChinaThe First Affiliated Hospital, Wenzhou Medical University, Wenzhou 325035, ChinaMGCD0103, an isotype-selective histone deacetylase inhibitor (HDACi), has been clinically evaluated for the treatment of hematologic malignancies and advanced solid tumors, alone and in combination with standard-of-care agents. In order to investigate the effects of MGCD0103 on the metabolic capacity of cytochrome P450 (CYP) enzymes, a cocktail method was employed to evaluate the activities of human CYP2B1, CYP1A2, CYP2C11, CYP2D6, CYP3A4, and CYP2C9. The rats were randomly divided into MGCD0103 group (Low, Medium, and High) and control group. The MGCD0103 group rats were given 20, 40, and 80 mg/kg (Low, Medium, and High) MGCD0103 by continuous intragastric administration for 7 days. Six probe drugs, bupropion, phenacetin, tolbutamide, metoprolol, testosterone, and omeprazole, were given to rats through intragastric administration, and the plasma concentrations were determined by UPLC-MS/MS. Statistical pharmacokinetics difference for tolbutamide in rats were observed by comparing MGCD0103 group with control group. Continuous 7-day intragastric administration of MGCD0103 slightly induces the activities of CYP2C11 of rats.http://dx.doi.org/10.1155/2015/517295 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Jinzhang Cai Qingwei Zhang Kezhi Lin Lufeng Hu Yuancai Zheng |
spellingShingle |
Jinzhang Cai Qingwei Zhang Kezhi Lin Lufeng Hu Yuancai Zheng The Effect of MGCD0103 on CYP450 Isoforms Activity of Rats by Cocktail Method BioMed Research International |
author_facet |
Jinzhang Cai Qingwei Zhang Kezhi Lin Lufeng Hu Yuancai Zheng |
author_sort |
Jinzhang Cai |
title |
The Effect of MGCD0103 on CYP450 Isoforms Activity of Rats by Cocktail Method |
title_short |
The Effect of MGCD0103 on CYP450 Isoforms Activity of Rats by Cocktail Method |
title_full |
The Effect of MGCD0103 on CYP450 Isoforms Activity of Rats by Cocktail Method |
title_fullStr |
The Effect of MGCD0103 on CYP450 Isoforms Activity of Rats by Cocktail Method |
title_full_unstemmed |
The Effect of MGCD0103 on CYP450 Isoforms Activity of Rats by Cocktail Method |
title_sort |
effect of mgcd0103 on cyp450 isoforms activity of rats by cocktail method |
publisher |
Hindawi Limited |
series |
BioMed Research International |
issn |
2314-6133 2314-6141 |
publishDate |
2015-01-01 |
description |
MGCD0103, an isotype-selective histone deacetylase inhibitor (HDACi), has been clinically evaluated for the treatment of hematologic malignancies and advanced solid tumors, alone and in combination with standard-of-care agents. In order to investigate the effects of MGCD0103 on the metabolic capacity of cytochrome P450 (CYP) enzymes, a cocktail method was employed to evaluate the activities of human CYP2B1, CYP1A2, CYP2C11, CYP2D6, CYP3A4, and CYP2C9. The rats were randomly divided into MGCD0103 group (Low, Medium, and High) and control group. The MGCD0103 group rats were given 20, 40, and 80 mg/kg (Low, Medium, and High) MGCD0103 by continuous intragastric administration for 7 days. Six probe drugs, bupropion, phenacetin, tolbutamide, metoprolol, testosterone, and omeprazole, were given to rats through intragastric administration, and the plasma concentrations were determined by UPLC-MS/MS. Statistical pharmacokinetics difference for tolbutamide in rats were observed by comparing MGCD0103 group with control group. Continuous 7-day intragastric administration of MGCD0103 slightly induces the activities of CYP2C11 of rats. |
url |
http://dx.doi.org/10.1155/2015/517295 |
work_keys_str_mv |
AT jinzhangcai theeffectofmgcd0103oncyp450isoformsactivityofratsbycocktailmethod AT qingweizhang theeffectofmgcd0103oncyp450isoformsactivityofratsbycocktailmethod AT kezhilin theeffectofmgcd0103oncyp450isoformsactivityofratsbycocktailmethod AT lufenghu theeffectofmgcd0103oncyp450isoformsactivityofratsbycocktailmethod AT yuancaizheng theeffectofmgcd0103oncyp450isoformsactivityofratsbycocktailmethod AT jinzhangcai effectofmgcd0103oncyp450isoformsactivityofratsbycocktailmethod AT qingweizhang effectofmgcd0103oncyp450isoformsactivityofratsbycocktailmethod AT kezhilin effectofmgcd0103oncyp450isoformsactivityofratsbycocktailmethod AT lufenghu effectofmgcd0103oncyp450isoformsactivityofratsbycocktailmethod AT yuancaizheng effectofmgcd0103oncyp450isoformsactivityofratsbycocktailmethod |
_version_ |
1725626313734094848 |